Market Place
Sourcing Support
Pharming Group Announces Starts Ph2 Trial Of Leniolisib For PIDs
10 Oct 2024 //
GLOBENEWSWIRE
Pharming Gets UK Marketing Authorization For Joenja
26 Sep 2024 //
GLOBENEWSWIRE
Pharming Updates On Leniolisib Review For APDS In Europe
30 May 2024 //
GLOBENEWSWIRE
Pharming Group Q1 2024 Results, Business Update
08 May 2024 //
GLOBENEWSWIRE
Pharming Honored as NORD Innovator
24 Apr 2024 //
GLOBENEWSWIRE
Pharming Announces Completion of Enrollment in Pediatric Trial of Leniolisib
08 Apr 2024 //
GLOBENEWSWIRE
Pharming Group announces development plans for leniolisib
13 Dec 2023 //
GLOBENEWSWIRE
Pharming announces development plans for leniolisib for additional PIDs
13 Dec 2023 //
GLOBENEWSWIRE
Pharming announces first patient dosed in pediatric trial for leniolisib
21 Nov 2023 //
GLOBENEWSWIRE
Pharming Group provides updates on EMA regulatory review of leniolisib MAA
10 Nov 2023 //
GLOBENEWSWIRE
Pharming announces first patient enrolled in Phase III trial of leniolisib
09 Aug 2023 //
PR NEWSWIRE
Pharming Gets FDA Nod for Joenja
27 Mar 2023 //
CONTRACT PHARMA
Pharming Stock Reaps Significant Gains After Landmark FDA Approval
25 Mar 2023 //
RTTNEWS
Pharming announces first patient enrolled in pediatric trial of leniolisib
21 Feb 2023 //
PR NEWSWIRE
Pharming announces positive data from open-label extension study of leniolisib
15 Dec 2022 //
PRNEWSWIRE
Pharming Announces (EMA) Validates its Marketing Authorisation for leniolisib
28 Oct 2022 //
PRNEWSWIRE
Pharming Announces EMA Validates its MAA under Assessment for leniolisib
27 Oct 2022 //
PRNEWSWIRE
Pharming submits a Marketing Authorisation Application to the EMA for Leniolisib
11 Oct 2022 //
PRNEWSWIRE
Pharming files rare disease drug leniolisib in Europe
11 Oct 2022 //
PHARMAPHORUM
Pharming Announces FDA Acceptance for Priority Review of its NDA for Leniolisib
28 Sep 2022 //
TAIWANNEWS
Pharming reports positive results from phase II/III study of leniolisib
03 Feb 2022 //
PHARMABIZ
EC Grants Orphan Drug Designation to Pharming’s Leniolisib
23 Oct 2020 //
PHARMTECH
Pharming’s APDS drug scores EU orphan status
22 Oct 2020 //
PHARMATIMES
Pharming receives Orphan Drug from the European Commission for leniolisib
20 Oct 2020 //
PHARMIWEB
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.